REGULATORY

• Govt Unveils Draft Honebuto Paper for 2021, Cabinet OK Expected after Party Tweaks
  June 10, 2021

• Japan PM Vows to Vaccinate All People by October-November
  June 10, 2021

• LDP Panel Urges 500 Billion Yen Support over 10 Years for Japan-Made Jabs
  June 9, 2021

• Japan Aims for 80% Generic Share in All Prefectures by FY2023-End: Honebuto Draft
  June 9, 2021

• 33 New Products Including Celecoxib Added to 18th Edition of Japanese Pharmacopoeia
  June 8, 2021

• G7 Health Ministers Adopt Declaration Aimed at Greater Cooperation to Expedite Drug, Vaccine Development
  June 8, 2021

• Label Revision Ordered for Clozaril to Increase Blood Testing Interval, Relaxed Re-Administration Criteria
  June 4, 2021

• MHLW Mulls Sakigake System for SaMD with Medical Device as a Model: Official
  June 3, 2021

• LDP Group on Generics Calls for Sustainable Supply Scheme: Proposal
  June 3, 2021

• Japan to Establish Ecosystem to Deliver Innovative Drugs: Draft Growth Strategy
  June 3, 2021

• Deregulation Panel Prods Govt to Fuel SaMD Development
  June 3, 2021

• Govt to Build R&D Data Utilization Platform at AMED
  June 3, 2021

• Nonpartisan Lawmakers’ Group Launched for Dementia Measures
  June 2, 2021

• Japan Cabinet Hammers Out Strategy to Boost Vaccine Development
  June 2, 2021

• Japan to Roll Out COVID-19 Vaccines at Workplaces from June 21
  June 2, 2021

• Blue Letter Issued to OA Drug Joyclu after Anaphylaxis Reports
  June 2, 2021

• Manufacturing and Use of Cannabis-Derived Drugs Should Be Permitted: MHLW Panel
  June 2, 2021

• Eisai’s EZH2 Inhibitor, 3 More New Drugs Clear Key Panel, June OK Likely
  May 31, 2021

• Panel OK’s Pfizer Vaccine Use in Age 12-Plus, Longer Refrigerator Storage
  May 31, 2021

• Olumiant Added to MHLW’s COVID-19 Guide as Approved Drug
  May 28, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 145
• 146
• 147
• 148
• 149
• 150
• 151
• 152
• 153
• …
• Next ›
• 最終 »